Lixte Biotechnology Warrants
LIXTW
LIXTW was delisted on the 26th of November, 2025.
4 hedge funds and large institutions have $7.32K invested in Lixte Biotechnology Warrants in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
31% more capital invested
Capital invested by funds: $5.6K → $7.32K (+$1.71K)
0.06% less ownership
Funds ownership: 0.59% → 0.53% (-0.06%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$6.05K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.26K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$92 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$7.06K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$602 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $4.58K | +$6.05K | +53,181 | New |
|
|
CS
2
Clear Street
New York
| $2K | -$7.06K | -62,057 | -73% |
|
|
3
Citadel Advisors
Miami,
Florida
| $664 | +$1.26K | +11,067 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $70 | +$92 | +811 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$602 | -12,806 | Closed |
|
LIXTW Hedge Fund Activity: Q1 2023 in Review
4 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q1 2023, worth a combined $7.32K — up 31% from $5.6K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new LIXTW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $6.05K. The largest seller was Clear Street, cutting an estimated $7.06K.
- 4 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q1 2023, up from 2 in Q4 2022.
- Funds reported $7.32K of Lixte Biotechnology Warrants stock for Q1 2023, up 31% quarter-over-quarter.
- 3 funds opened new Lixte Biotechnology Warrants positions in Q1 2023 and 1 closed out, a net change of +2 holders.
- The largest Lixte Biotechnology Warrants buyer in Q1 2023 was Warberg Asset Management, an estimated $6.05K added.
- The largest Lixte Biotechnology Warrants seller in Q1 2023 was Clear Street, an estimated $7.06K sold.
Based on aggregated 13F filings for Q1 2023.